NEWS

Access to this information is limited to authorized persons who are resident and physically present in jurisdictions outside the United States, Canada, Japan or Australia, South Africa and any other jurisdiction in which the offer or sale of securities of the Company is unlawful.

The information contained in this section of the website of Vivoryon Therapeutics N.V. is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America, Australia, Canada, Japan or South Africa or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.